Skip to content

3D Printing-Bioscaffold Synergy for Precision Repair of Alveolar Cleft: A Study on Osteogenic Efficacy and Translational Application

3D-Printed Biphasic Scaffolds for Alveolar Cleft Repair: A Study on Surgical Outcome and Translational Applications

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122014
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Cleft

Interventions

Group A:Bmac-loaded ß-TCP-CMC-Na scaffold prosthesis with 3D printing personalized shaping technology
Group B:Only BMAC was used to load on ß-TCP particles, without binding to CMC-Na gel
Group C:Repair was carried out with autologous iliac bone graft (gold standard).

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Unilateral alveolar cleft confirmed by imaging examination. 2. No prior surgical repair for alveolar cleft. 3. No evidence of bone metabolic disorders. 4. No signs of infection in the surgical area. 5. The participant and/or their legal guardian agrees to participate in this trial and provides signedinformed consent. 6. Not currently participating in any other clinical trial.

Exclusion criteria

Exclusion criteria: 1. History of previous surgical repair for alveolar cleft. 2. History of previous maxillary surgery. 3. Presence of systemic infection or local infection at the surgical site. 4. History or related examination abnormalities of other bone metabolic diseases (e.g.,osteoporosis, osteomalacia)that may affect bone healing. 5. Preoperative evaluation indicating intolerance to general anesthesia or any other conditionrendering the patient unsuitable for surgery. 6. Inability to cooperate with preoperative assessments or required examinations during the trialperiod. 7. Currently participating in another clinical trial and has not yet reached the study endpoint.

Design outcomes

Primary

MeasureTime frame
Osteogenesis rate (OR);Bone mineral density (BMD);

Secondary

MeasureTime frame
Degree of graft congruence with the preoperative 3D model;

Countries

China

Contacts

Public ContactYongqian Wang

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

surgeonfrank2023@163.com+86 10 5396 8150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026